Related to Cepheid Gets $1.3M to Develop Sample Prep Methods for Detecting Bloodstream Bacteria

• NCI Awards $19.3M Grant to Study Breast Cancer Disparity Between African-American and European Women
  
• HemoShear Wins $4.3M NIH Grant to Develop Predictive Drug Database
  
• Selecta Wins SAIC Subcontract to Develop Synthetic Nanoparticle Malaria Vaccine
  
• GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
  
• Theralpha Wins €2.55M in Funding to Take Snake Venom Analgesic into Early Clinical Trials
  
• Aura Raises $4.5M and Signs CRADA for Diagnostic and Therapeutic Nanoparticle Platform
  
• Diamyd Gets $3M to Develop Treatment for Chemotherapy-Induced Peripheral Neuropathy
  
• Aduro BioTech Wins $250K in SBIR Grants and Contract with UNM for Vaccine Development
  
• Investigators Get $8M to Set Up Parkinson’s Brain Bank
  
• BioMarker Wins SBIR NCI Grant to Develop Phosophoprotein-Based Companion Diagnostic
  
• NeuroVive and to-BBB Get €1M Boost to Stroke Therapy Collaboration
  
• G-Zero Awarded $3.6M to Advance Pharmacoquiescence Approach to Radiomitigation
  
• NIPTE Receives $35M from FDA to Reform Drug Manufacturing Standards
  
• United Therapeutics Wins NIAID Contract Worth $45M to Develop Broad-Spectrum Antiviral Drug
  
• MJFF Awards AFFiRiS $1.5M for Phase I Study with Peptide-Based Parkinson Disease Vaccine
  
• Wellcome Trust Gives PsiOxus £1.8M to Take Oncolytic Virus into Clinical Development
  
• Arsanis Wins €1.2M for Research on Antibody Against Hospital-Acquired Infections
  
• New England Research Institutes Scores $45M to Support the Pediatric Heart Network
  
• California Institute for Reg Med Agrees to Dole Out $30M to Foster Alliances with Industry
  
• NCI Provides $196K for Labcyte and Canary Center to Develop New Cancer Biomarker System